Katsuhiko Warita

Dr. Katsuhiko Warita


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 June 2018 in Oncotarget
Verified
Journal Article
Open access
PDF file
TITakuro Ishikawa
Takuro Ishikawa
YHYoshinao Z. Hosaka
Yoshinao Z. Hosaka
CBColin Beckwitt
Colin Beckwitt
AWAlan Wells
Alan Wells
ZOZoltan N. Oltvai
Zoltan N. Oltvai
KWKatsuhiko Warita
Katsuhiko Warita
Oncotarget | https://doi.org/10.18632/oncotarget.25448 Takuro Ishikawa, Yoshinao Z. Hosaka, Colin Beckwitt, Alan Wells, Zoltán N. Oltvai, Katsuhiko Warita Concomitant attenuation of HMG-CoA reductase expression potentiates the cancer cell growth-inhibitory effect of statins and expands their efficacy in tumor cells with epithelial characteristics


21 October 2016 in Marine Drugs
Verified
Journal Article
Open access
PDF file
KWKatsuhiko Warita
Katsuhiko Warita
NONana Oshima
Nana Oshima
NTNaoko Takeda-Okuda
Naoko Takeda-Okuda
JTJun-Ichi Tamura
Jun-Ichi Tamura
YHYoshinao Hosaka
Yoshinao Hosaka
Chondroitin sulfate (CS), a type of glycosaminoglycan (GAG), is a factor involved in the suppression of myogenic differentiation. CS comprises two repeating sugars and has different subtypes depending on the position and number of bonded sulfate groups. However, the effect of each subtype on myogenic differentiation remains unclear. In this study, we spiked cultures of C2C12 myoblasts, cells which are capable of undergoing skeletal muscle differentiation, with one of five types of CS (CS-A, -B, -C, -D, or -E) and induced differentiation over a fixed time. After immunostaining of the formed myotubes with an anti-MHC antibody, we counted the number of nuclei in the myotubes and then calculated the fusion index (FI) as a measure of myotube differentiation. The FI values of all the CS-treated groups were lower than the FI value of the control group, especially the group treated with CS-E, which displayed notable suppression of myotube formation. To confirm that the sugar chain in CS-E is important in the suppression of differentiation, chondroitinase ABC (ChABC), which catabolizes CS, was added to the media. The addition of ChABC led to the degradation of CS-E, and neutralized the suppression of myotube formation by CS-E. Collectively, it can be concluded that the degree of suppression of differentiation depends on the subtype of CS and that CS-E strongly suppresses myogenic differentiation. We conclude that the CS sugar chain has inhibitory action against myoblast cell fusion.